Paper42889151PubMed
The selective SIK2/3 inhibitor GLPG3970 exhibits antidepressant-like effects via the hippocampal SIK2-CRTC1-CREB-BDNF pathway in chronic stress models.
Shen JY and 8 others. Front Pharmacol, 2026.
Cite this record
ConductScience Library. The selective SIK2/3 inhibitor GLPG3970 exhibits antidepressant-like effects via the hippocampal SIK2-CRTC1-CREB-BDNF pathway in chronic stress models. Papers, record 42889151. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42889151
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The selective SIK2/3 inhibitor GLPG3970 exhibits antidepressant-like effects via the hippocampal SIK2-CRTC1-CREB-BDNF pathway in chronic stress models.
- Journal
- Front Pharmacol
- Year
- 2026
- Publication types
- Journal Article
- Revised in PubMed
- 2026-10-19
Source PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References68
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35853529 | Neuromodulation and hippocampal neurogenesis in depression: A scoping review. | Brain Res Bull | 2022 | https://conductscience.org/library/papers/35853529 | PubMed |
| 2 | 32416107 | Inhibition of ferroptosis attenuates busulfan-induced oligospermia in mice. | Toxicology | 2020 | https://conductscience.org/library/papers/32416107 | PubMed |
| 3 | 40849324 | Modulation of neuroimmune cytokine networks by antidepressants: implications in mood regulation. | Transl Psychiatry | 2025 | https://conductscience.org/library/papers/40849324 | PubMed |
| 4 | 10618023 | Hippocampal volume reduction in major depression. | Am J Psychiatry | 2000 | https://conductscience.org/library/papers/10618023 | PubMed |
| 5 | 32759272 | Potent Therapy and Transcriptional Profile of Combined Erythropoietin-Derived Peptide Cyclic Helix B Surface Peptide and Caspase-3 siRNA against Kidney Ischemia/Reperfusion Injury in Mice. | J Pharmacol Exp Ther | 2020 | https://conductscience.org/library/papers/32759272 | PubMed |
| 6 | 33234364 | Naringenin alleviates nonalcoholic steatohepatitis in middle-aged Apoe-/-mice: role of SIRT1. | Phytomedicine | 2021 | https://conductscience.org/library/papers/33234364 | PubMed |
| 7 | 23972989 | Regulation of cyclic AMP response element binding and hippocampal plasticity-related genes by peroxisome proliferator-activated receptor α. | Cell Rep | 2013 | https://conductscience.org/library/papers/23972989 | PubMed |
| 8 | 34053675 | Brain-Derived Neurotrophic Factor Signaling in Depression and Antidepressant Action. | Biol Psychiatry | 2021 | https://conductscience.org/library/papers/34053675 | PubMed |
| 9 | 19442174 | Monoaminergic neurotransmission: the history of the discovery of antidepressants from 1950s until today. | Curr Pharm Des | 2009 | https://conductscience.org/library/papers/19442174 | PubMed |
| 10 | 18923511 | The molecular neurobiology of depression. | Nature | 2008 | https://conductscience.org/library/papers/18923511 | PubMed |
| 11 | 22826347 | Beyond the monoaminergic hypothesis: neuroplasticity and epigenetic changes in a transgenic mouse model of depression. | Philos Trans R Soc Lond B Biol Sci | 2012 | https://conductscience.org/library/papers/22826347 | PubMed |
| 12 | 37197708 | Longitudinal trajectories of anxiety, depression, and bipolar disorder in inflammatory bowel disease: a population-based cohort study. | EClinicalMedicine | 2023 | https://conductscience.org/library/papers/37197708 | PubMed |
| 13 | 32202179 | Inhibition of tanshinone IIA on renin activity protected against osteoporosis in diabetic mice. | Pharm Biol | 2020 | https://conductscience.org/library/papers/32202179 | PubMed |
| 14 | 30720699 | Major Depressive Disorder in Medical Illness: A Review of Assessment, Prevalence, and Treatment Options. | Psychosom Med | 2019 | https://conductscience.org/library/papers/30720699 | PubMed |
| 15 | 30627806 | Monoaminergic system and depression. | Cell Tissue Res | 2019 | https://conductscience.org/library/papers/30627806 | PubMed |
| 16 | 40123457 | Brain-Derived Neurotrophic Factor (BDNF) in Huntington's Disease: Neurobiology and Therapeutic Potential. | Curr Neuropharmacol | 2025 | https://conductscience.org/library/papers/40123457 | PubMed |
| 17 | 21346730 | CREB and the CRTC co-activators: sensors for hormonal and metabolic signals. | Nat Rev Mol Cell Biol | 2011 | https://conductscience.org/library/papers/21346730 | PubMed |
| 18 | 36434056 | Salt-inducible kinase 1-CREB-regulated transcription coactivator 1 signalling in the paraventricular nucleus of the hypothalamus plays a role in depression by regulating the hypothalamic-pituitary-adrenal axis. | Mol Psychiatry | 2024 | https://conductscience.org/library/papers/36434056 | PubMed |
| 19 | 33519490 | The Selective SIK2 Inhibitor ARN-3236 Produces Strong Antidepressant-Like Efficacy in Mice via the Hippocampal CRTC1-CREB-BDNF Pathway. | Front Pharmacol | 2020 | https://conductscience.org/library/papers/33519490 | PubMed |
| 20 | 39513407 | Effects of GLPG3970 on Sulfasalazine and Methotrexate Pharmacokinetics in Healthy Adults: Two Open-Label, Phase I, Drug-Drug Interaction Studies. | Clin Pharmacol Ther | 2025 | https://conductscience.org/library/papers/39513407 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42889151
GET https://conductscience.org/api/papers/v1/42889151/references?page=2